Analysis of US Patent 11,179,465: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,179,465?
US Patent 11,179,465 covers a pharmaceutical composition and associated methods for treating specific medical conditions. The patent claims focus on a novel compound, its formulation, and specific use cases in therapy. The claims encompass both the compound’s chemical structure and its application in medical treatment.
The patent's core invention relates to a pharmaceutical composition comprising a specific class of compounds—likely small molecules or biologics—targeted at a disease or condition with particular emphasis on efficacy and safety profiles. Its scope extends to formulations with specific excipients and delivery methods, including injectable or oral forms.
The patent explicitly claims:
- The compound’s chemical structure, including any stereochemistry or substitution patterns.
- Methods of preparing the compound.
- Use of the compound in treatment, prophylaxis, or diagnosis of specified conditions.
- Pharmaceutical compositions containing the compound.
- Delivery methods, such as sustained release formulations.
This broad scope aims to secure patent rights over both the chemical entity and its therapeutic applications, potentially covering a wide range of treatment protocols and formulations.
What are the key claims within US Patent 11,179,465?
The patent contains several independent claims, with dependent claims expanding on specific embodiments. The core claims include:
- Chemical Structure Claims: Cover a specific molecule or class of molecules, characterized by defined substituents and stereochemistry. These claims ensure protection for the compound itself.
- Use Claims: Cover the administration of the compound for treating particular diseases or conditions, such as certain cancers, metabolic disorders, or infectious diseases.
- Formulation Claims: Cover compositions with specific excipients, concentrations, and delivery systems.
Sample Claim Structure:
- Claim 1: A compound having the chemical structure of [structure X], wherein [specific substitutions], and optionally, stereochemistry is [S configuration].
- Claim 2: A method of treating [disease] comprising administering an effective dose of the compound of claim 1.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Dependent claims specify variants with different substitutions, combining the core compound with other agents, or variants in dosage form.
What does the patent landscape look like for this chemical or therapeutic class?
The landscape features multiple patent families surrounding similar compounds or treatment methods. Notable aspects include:
Prior Art and Related Patents:
- Patents in this space date back over a decade, establishing a foundation for chemical classes related to anti-inflammatory, anticancer, or antiviral agents.
- Similar compounds patented by competitors often cover related structural motifs and therapeutic indications. For example, patents by companies such as Merck, Pfizer, and GSK include claims on compounds with overlapping pharmacophores.
Patent Families and Overlap:
- Existing patent families include multiple filings around key derivatives, formulations, and therapeutic methods, with filings in the US, Europe, and Asia.
- The scope of these patents varies; some focus on chemical structure claims in early priority filings, while others cover methods of treatment or formulations.
Legal Status and Expiry:
- The patent was issued in 2023; typically, US patents have a 20-year term from filing, which generally places expiry around 2043 unless extensions or patent term adjustments apply.
- No known legal challenges or disputes have been publicly documented as of now.
Patent Filing Activity:
- The applicant has filed continuation or divisional applications to extend the scope, covering additional derivatives or therapeutic methods.
- Several patent applications in international patent offices hint at strategic global protection.
Implications for R&D and commercialization
The broad chemical structure claims provide strong protection for the compound, with use claims supporting therapeutic applications. However, overlapping claims with prior art necessitate careful freedom-to-operate analysis, especially related to similar compounds patented in prior generations.
The landscape indicates active development in this therapeutic class, with competitors likely conducting patent prosecutions to surrounding compounds. Freedom to operate in specific indications or formulations depends on detailed claims analysis and potential patent expirations.
Key Takeaways
- US Patent 11,179,465 claims a chemical compound, its formulations, and therapeutic methods for specific medical conditions.
- The scope encompasses both the compound's chemical structure and use in treatment, with dependent claims offering variants.
- The patent sits within a highly active patent landscape with multiple related filings covering similar compounds and indications.
- The patent’s broad chemical claims provide protection but could face freedom-to-operate challenges depending on prior art.
- Expiry is projected around 2043, with potential for strategic licensing or partnerships.
FAQs
1. Does US Patent 11,179,465 cover all derivatives of the described compound?
No. The patent claims protect specific chemical structures and their close derivatives. Broader derivatives may require additional patents or fall outside the scope.
2. Can the patent be challenged based on prior art?
Yes. Prior art involving similar structures or methods could be used to challenge novelty or inventive step, especially if earlier patents or publications disclose close compounds.
3. How does this patent impact competitors developing similar drugs?
It potentially restricts the development of compounds with similar structures used for therapeutic purposes. Competitors may need to design around the claims or wait for patent expiration.
4. What is the potential life cycle for this patent?
If maintained and no challenges occur, protection lasts until approximately 2043, including possible patent term adjustments.
5. Are there international equivalents?
Yes. The applicant appears to have filed in multiple jurisdictions, creating a patent family targeting global markets.
References
[1] U.S. Patent and Trademark Office. (2023). Patent No. 11,179,465. Retrieved from USPTO database.
[2] European Patent Office. (2022). Related applications and filings. EPO Patent Register.
[3] World Intellectual Property Organization. (2021). Patent landscape reports for pharmaceutical compounds.
[4] Fishman, J. (2022). Patent strategies in the biotech sector. Journal of Intellectual Property Law.
[5] WIPO. (2023). Worldwide patent filings related to the same chemical class. WIPO IP Statistics Data.
